Inmune Bio, Inc. (INMB) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $50.0K | +257.1% |
| 2024 | $14.0K | -91.0% |
| 2023 | $155.0K | -58.6% |
| 2022 | $374.0K | +106.6% |
| 2021 | $181.0K | +1545.5% |
| 2020 | $11.0K | — |
| 2018 | $0 | — |
| 2017 | $0 | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $50.0K | +257.1% |
| 2024 | $14.0K | -91.0% |
| 2023 | $155.0K | -58.6% |
| 2022 | $374.0K | +106.6% |
| 2021 | $181.0K | +1545.5% |
| 2020 | $11.0K | — |
| 2018 | $0 | — |
| 2017 | $0 | — |